课题基金 / 基金详情

HIV latency, pathogenesis and immunity

HIV latency, pathogenesis and immunity
HIV潜伏期、发病机制和免疫
批准号:
nhmrc : 1052979
负责人:
Prof Anthony Kelleher
金额:
$882.36万
依托单位国家:
澳大利亚
项目类别:
Program Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 2018-12-31

项目摘要

项目成果

Prof Anthony Kelleher的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The development of cures, vaccines and better treatments for HIV/AIDS is an urgent global health priority. This team of seven groups in Sydney and Melbourne will study how HIV can lie dormant in some parts of the body, evading eradication by HIV therapy, as well as how the immune system responds to the virus. This will allow for design of novel vaccines and treatments. The researchers have skills in basic virology and immunology, and translating laboratory findings into human clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing the major challenges in HIV vaccine and cure research
  • 批准号:
    nhmrc : 1149990
  • 项目类别:
    Program Grants
  • 资助金额:
    $1076.0万
  • 财政年份:
    2019
  • 负责人:
    Prof Anthony Kelleher
  • 依托单位:
Immunopathogenesis and manipulation of the HIV reservoir
  • 批准号:
    nhmrc : 1117907
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $32.99万
  • 财政年份:
    2017
  • 负责人:
    Prof Anthony Kelleher
  • 依托单位:
European AIDS Vaccine Initiative 2020
  • 批准号:
    nhmrc : GNT1115828
  • 项目类别:
    International Collaborations
  • 资助金额:
    $50.0万
  • 财政年份:
    2016
  • 负责人:
    Prof Anthony Kelleher
  • 依托单位:
European AIDS Vaccine Initiative 2020
  • 批准号:
    nhmrc : 1115828
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $34.47万
  • 财政年份:
    2016
  • 负责人:
    Prof Anthony Kelleher
  • 依托单位:
国内基金
海外基金
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究